Vsaar Pharma Private Limited

Vsaar Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2012PTC033851 Incorporated 08 June 2012 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma
Revenue · FY 2025
₹4.24 Cr
▼ 1% YoY
Net profit · FY 2025
₹35,621
Net margin 0.1%
EBITDA · FY 2025
₹5.19 Lakh
EBITDA margin 1.2%
Authorised capital
₹9 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Open charges
₹12.73 Lakh
Satisfied ₹75 Lakh
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings

About Vsaar Pharma Private Limited

Data last updated:

Vsaar Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC033851. Its GSTIN is 04AAECV0763C2ZQ (Chandigarh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Rakesh Kumar Rana (Whole-Time Director) and Radhe Sham Goyal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 165 Sector 38 C, Chandigarh, India – 160038.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.24 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹35,621 (net margin 0.1%) and EBITDA of ₹5.19 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 4% over five years.

As per MCA filings, the company has open charges of ₹12.73 Lakh and satisfied charges of ₹75 Lakh on record. Court records list 14 cases involving the company, including 13 filed by the company and 1 filed against it; 5 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232CH2012PTC033851
Registration Number 033851
Incorporation Date 08 June 2012
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Vsaar Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    SCO 165 Sector 38 C, Chandigarh, India – 160038
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vsaar Pharma Private Limited, buy the company report.

Comprehensive company report
Vsaar Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Vsaar Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Vsaar Pharma Private Limited, buy the company report.

Financials of Vsaar Pharma Private Limited

FY 2025 filings available

Vsaar Pharma Private Limited reported revenue of ₹4.24 Cr (down 1% YoY) for FY 2025.

Revenue · FY 2025
₹4.24 Cr ▼ 1%
Net profit · FY 2025
₹35,621 margin 0.1%
EBITDA · FY 2025
₹5.19 Lakh margin 1.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 10%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 40%
3 years · compounded
▼ 26%
5 years · compounded
▼ 25%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.19 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹35,621
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.2%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vsaar Pharma Private Limited, buy the company report.

Board of directors of Vsaar Pharma Private Limited

Vsaar Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Radhe Sham GoyalDirector08 Jun 201214 Years 5 MonthsCurrent
Sumit KumarDirector21 Apr 20215 Years 6 MonthsCurrent
Rakesh Kumar RanaWhole-Time Director01 Apr 20215 Years 7 MonthsCurrent

Peer comparison

Vsaar Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
VV Labs Private Limited₹4.26 Cr (FY 2025)9.0%Hyderabad, Telangana, India
Zenwick Pharma Private Limited₹4.25 Cr (FY 2025)66.0%Maliankara P.O, Ernakulam, Kerala, India
Abibba Pharmaa Private Limited₹4.24 Cr (FY 2025)2.0%Chandigarh, India
Vsaar Pharma Private Limitedthis company₹4.24 Cr (FY 2025)₹35,6210.1%-1.0%Chandigarh, India
Kobun Techno Pharma (OPC) Private Limited₹4.24 Cr (FY 2025)-2.0%Ranchi, Jharkhand, India
Luzerne Life Sciences Private Limited₹4.21 Cr (FY 2020)43.0%Kochi, Kerala, India

To see the full peer comparison of Vsaar Pharma Private Limited, buy the company report.

Auditor

Vsaar Pharma Private Limited is audited by MGSG & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MGSG & ASSOCIATESFY 2023033841N

Shareholding

The shareholding of Vsaar Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vsaar Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12.73 Lakh
Satisfied charges
₹75 Lakh
Breakdown by lending institutions
Axis Bank Limited₹0.13 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Sep 2020100371658Axis Bank Limited₹12.73 LakhOpen
10 Dec 201310467364Axis Bank Limited₹75 LakhSatisfied

To see the full charge records of Vsaar Pharma Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Vsaar Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
GG Nutrition

To see the full MSME payment records of Vsaar Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Vsaar Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
04AAECV0763C2ZQChandigarhActive16 Sep 2019
03AAECV0763C1ZTPunjabActive28 Mar 2023

To see the full GST registrations and return filing status of Vsaar Pharma Private Limited, buy the company report.

Recent activity

Vsaar Pharma Private Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Sumit Kumar was appointed as Director on 21 Apr 2021.

AGM
Vsaar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vsaar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Sumit Kumar was appointed as Director.
Appointed
Rakesh Kumar Rana was appointed as Whole-Time Director.
Ceased
Vinod Kumar ceased to be Whole-Time Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 12.73 Lakh with Charge ID 100371658 was registered on 03 Sep 2020.
Ceased
Jagan Nath Gupta ceased to be Director.
Charges
A charge registered on 10 Dec 2013 via Charge ID 10467364 with Axis Bank Limited was fully satisfied on 27 Feb 2019.
Ceased
Ved Prakash Aggarwal ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 10467364 was registered on 10 Dec 2013.
Appointed
Radhe Sham Goyal was appointed as Director.
Incorporation
08 Jun 2012
Vsaar Pharma Private Limited was registered on 08 Jun 2012 with Roc Chandigarh & aged 14 years 5 months as per MCA records.

Frequently asked questions

Vsaar Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2012 (14+ years old) and is registered under CIN U24232CH2012PTC033851.

Vsaar Pharma has 3 current directors:

The latest financial statements of Vsaar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Vsaar Pharma is 04AAECV0763C2ZQ, registered in Chandigarh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AAECV0763C1ZT (Punjab).

The CIN (Corporate Identification Number) of Vsaar Pharma is U24232CH2012PTC033851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vsaar Pharma has 14 court cases on record: 13 filed by the company and 1 filed against it. 5 are pending. Most are in the district courts.

Vsaar Pharma was incorporated on 08 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Vsaar Pharma by revenue are VV Labs Private Limited, Zenwick Pharma Private Limited, Abibba Pharmaa Private Limited, Kobun Techno Pharma (OPC) Private Limited, Luzerne Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Sumit Kumar was appointed as Director on 21 Apr 2021. Rakesh Kumar Rana was appointed as Whole-Time Director on 01 Apr 2021. Vinod Kumar ceased to be Whole-Time Director on 01 Apr 2021. Vsaar Pharma has 6 board changes on record in total.

Vsaar Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.

The registered office of Vsaar Pharma is at SCO 165 Sector 38 C, Chandigarh, India – 160038.

Vsaar Pharma operates in the pharma industry, in the drug formulation and development segment.